GBC seeks nominations for region’s second annual Bioscience Awards

The Greater Baltimore Committee is seeking nominations for the Second Annual Greater Baltimore Region Bioscience Awards to be held on March 14. Nominate a company or individual you know for an award. The four award categories are: Entrepreneurial Spirit, Best New Product or Progress, Leadership in Bioscience, and Academic/Industry Collaboration. Nominators will...
Read More...

In Vitro Technologies president reports lessons learned

Dr. Paul Silver learned many things about the biotech business in the 15 years between his founding of In Vitro Technologies in 1990 until the company’s sale in 2006 to Celsis International. But one key lesson stands out, according to Silber, who now serves as an advisor to Celsis In Vitro Technologies. “I learned that every business should run as if it’s preparing to sell,” Silber said at the January … Continue reading

Collaboration is key to ‘nanobio’ development, say experts at GBC conference

Maryland’s research universities are developing new levels of collaboration to make advances in the emerging field of nanobiology, said experts at a Nov. 28 GBC conference on nanomedicine. The conference at the Columbia Sheraton drew more than 50 scientists and advocates for Maryland’s development as a center for nanobiotechnology research and industry. Nanobiotechnology and nanomedicine involve the application of nanotechnology to the life sciences field. Nanotechnology is the creation and use … Continue reading

MedImmune’s Hockmeyer: Maryland beginning to generate ‘serial’ entrepreneurs

While there remains much work to do relating to technology transfer, public and private efforts to strengthen Maryland’s biotech business community are starting to show some signs of paying off, according to Dr. Wayne Hockmeyer, founder and chairman of MedImmune, the state’s largest biotech business. For instance, Maryland is beginning to generate “serial” entrepreneurs, Hockmeyer reported at the GBC’s September 27 Bioscience Speaker Series event. The series is part of … Continue reading

GBC’s Fry: Attracting bioscience workers to Maryland

Don Fry Commentary on WYPR A global bioscience company has 60 jobs open at its Rockville facility awaiting qualified candidates to fill them. A Germantown pharmaceuticals firm recently lost a senior executive to North Carolina. Why aren’t workers flocking to Maryland, a well-known bioscience research leader with what most who live here agree is a great quality of life? Recently, the Governor’s Workforce Investment Board asked recruiters what bioscience job … Continue reading

Demolition work to begin on east side life sciences and revitalization project

Demolition work is expected to begin within days to clear 500 vacant properties from a 31-acre site north of Johns Hopkins Medical Institutions to make way for the first phase of housing construction near a planned life sciences and technology park in the New East Baltimore Community. P & J Contracting Company, Inc., a minority-owned contractor, will perform the $8 million demolition project, East Baltimore Development Inc. announced last week. … Continue reading

Current Baltimore-area construction would add 620,000 square feet of bioscience space by 2008

Building projects now underway at three research parks in the Baltimore area will add 620,000 square feet of wet lab and research facilities to the region within two years, according to progress reports presented at the GBC’s May 16 bioscience event in Howard County. Managers of the biopark development projects near the University of Maryland, Baltimore; Johns Hopkins Medical Institutions, and University of Maryland Baltimore County offered updates on their … Continue reading

New Battelle study cites “comprehensive” bioscience development efforts in Maryland

Maryland continues to offer a “comprehensive set of efforts” to nurture bioscience industry growth, according to an April 2006 report from Battelle Technology Partnership on state bioscience initiatives. The report cites significant state government budgeting for capital expenditures, tax policy changes, and the development of two new bioscience parks in Baltimore City. It notes that tax policy changes made since 2004 include reauthorization of the research and development tax credit … Continue reading

East side bioscience groundbreaking marks milestone in region’s bioscience growth

Five standout science students from Dunbar High School dug their shovels into the dirt at the corner of Wolfe and Ashland Streets today marking the groundbreaking for the first bioscience building in The Science + Technology Park at Johns Hopkins. More than 100 dignitaries and business and community leaders celebrated the groundbreaking for the 282,000 square-foot building at 855 N. Wolfe Street as a major milestone in the massive revitalization … Continue reading

Army seeks small biotech firms as new consortium participants

The U.S. Army is seeking to tap the research and development resources of emerging bioscience companies through a new “consortium” and a streamlined procurement process for certain biotech-driven projects, a top Army biotech advisor told a Greater Baltimore Committee audience April 3. “We consider that biotech, in 25 years, will have the same total effect on military strategy as IT does now,” said Dr. James J. Valdes, scientific advisor for … Continue reading